SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Kumari, V.
Right arrow Articles by Gray, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumari, V.
Right arrow Articles by Gray, J. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

effects of d-amphetamine and haloperidol on latent inhibition in healthy male volunteers

Veena Kumari

Section of Cognitive Psychopharmacology, Department of Psychological Medicine, Institute of Psychiatry, De Crespigny Park, London SE5 8AF,UK v.kumari{at}iop.kcl.ac.ku

Paul A. Cotter

Owen F. Mulligan

Stuart A. Checkley

Department of Psychiatry, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, UK

Nicola S. Gray

David R. Hemsley

Jasper C. Thornton

Philip J. Corr

Department of Psychology, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, UK

Brian K. Toone

Department of Psychological Medicine, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, UK

Jeffrey A. Gray

Department of Psychology, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, UK

Latent inhibition (LI) refers to a retardation of learning about the consequences of a stimulus when that stimulus has been passively presented a number of times without reinforcement. Acute positive-symptom schizophrenics, normal volunteers who score high on questionnaire measures of schizotypy and non-patients or animals treated with dopamine agonists show reduced LI. Neuroleptic drugs, such as haloperidol, administered at low doses, potentiate LI and effectively reverse disruption of LI induced by dopamine agonists in animals. However, a high dose of haloperidol, administered on its own, has been found to reduce LI. We examined the effects on LI of acute oral administration of an indirect dopamine-agonist, d-amphetamine (5 mg), and a nonselective dopamine receptor antagonist, haloperidol (5 mg), in normal male volunteers, using an associative learning task. Replicating previous reports, we found that d-amphetamine reduced LI; haloperidol also reduced LI, but only in subjects who scored low on the Psychoticism scale of the Eysenck Personality Questionnaire. In a subsequent study, no effect was found of 2 mg oral haloperidol administration on LI. The effect of 5 mg haloperidol on LI is interpreted as similar to that observed with a high dose of haloperidol in rats.

Key Words: d-amphetamine • dopamine • haloperidol • latent inhibition • psychoticism • schizophrenia

Journal of Psychopharmacology, Vol. 13, No. 4, 398-405 (1999)
DOI: 10.1177/026988119901300411


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
H. Cassaday, B. Finger, and R. Horsley
Methylphenidate and nicotine focus responding to an informative discrete CS over successive sessions of appetitive conditioning
J Psychopharmacol, November 1, 2008; 22(8): 849 - 859.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
S. Grimond-Billa, C Norman, G. Bennett, and H. Cassaday
Selectively increased trace conditioning under the neurotensin agonist PD 149163 in an aversive procedure in which SR 142948A was without intrinsic effect
J Psychopharmacol, May 1, 2008; 22(3): 290 - 299.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
R.R. Horsley and H. J. Cassaday
Methylphenidate can reduce selectivity in associative learning in an aversive trace conditioning task
J Psychopharmacol, July 1, 2007; 21(5): 492 - 500.
[Abstract] [PDF]


Home page
Schizophr BullHome page
R E Lubow
Construct Validity of the Animal Latent Inhibition Model of Selective Attention Deficits in Schizophrenia
Schizophr Bull, January 1, 2005; 31(1): 139 - 153.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
E. Kantini, C. Norman, and H. J. Cassaday
Amphetamine decreases the expression and acquisition of appetitive conditioning but increases the acquisition of anticipatory responding over a trace interval
J Psychopharmacol, December 1, 2004; 18(4): 516 - 526.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
S. L. Barrett, R. Bell, D. Watson, and D. J. King
Effects of Amisulpride, Risperidone and Chlorpromazine on Auditory and Visual Latent Inhibition, Prepulse Inhibition, Executive Function and Eye Movements in Healthy Volunteers
J Psychopharmacol, June 1, 2004; 18(2): 156 - 172.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
K. M. Abel, S. Jolley, D. R. Hemsley, and M. A. Geyer
The Influence of Schizotypy Traits on Prepulse Inhibition in Young Healthy Controls
J Psychopharmacol, June 1, 2004; 18(2): 181 - 188.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
C. Norman and H. J. Cassaday
Amphetamine increases aversive conditioning to diffuse contextual stimuli and to a discrete trace stimulus when conditioned at higher footshock intensity
J Psychopharmacol, January 1, 2003; 17(1): 67 - 76.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
D. McCartan, R. Bell, J. F. Green, C. Campbell, K. Trimble, A. Pickering, and D. J. King
The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers
J Psychopharmacol, March 1, 2001; 15(2): 96 - 104.
[Abstract] [PDF]



Advertisement